BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22367574)

  • 1. Edema index established by a segmental multifrequency bioelectrical impedance analysis provides prognostic value in acute heart failure.
    Liu MH; Wang CH; Huang YY; Tung TH; Lee CM; Yang NI; Liu PC; Cherng WJ
    J Cardiovasc Med (Hagerstown); 2012 May; 13(5):299-306. PubMed ID: 22367574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
    J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
    J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive diagnostic and prognostic value of bioelectrical impedance vector analysis (BIVA) to brain natriuretic peptide 'grey-zone' in patients with acute heart failure in the emergency department.
    Di Somma S; Lalle I; Magrini L; Russo V; Navarin S; Castello L; Avanzi GC; Di Stasio E; Maisel A
    Eur Heart J Acute Cardiovasc Care; 2014 Jun; 3(2):167-75. PubMed ID: 24477201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of serum albumin and serum total cholesterol in the prediction of hospital death in older patients with severe, acute heart failure.
    Arques S; Roux E; Stolidi P; Gelisse R; Ambrosi P
    Arch Cardiovasc Dis; 2011 Oct; 104(10):502-8. PubMed ID: 22044702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis.
    Pimenta J; Paulo C; Gomes A; Silva S; Rocha-Gonçalves F; Bettencourt P
    Liver Int; 2010 Aug; 30(7):1059-66. PubMed ID: 20492497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure.
    Cournot M; Mourre F; Castel F; Ferrières J; Destrac S
    Am Heart J; 2008 Jun; 155(6):986-91. PubMed ID: 18513508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
    Glick A; Michowitz Y; Keren G; George J
    Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent and additive prognostic ability of serum carboxy-terminal telopeptide of collagen type-I in heart failure patients: a multi-marker approach with high-negative predictive value to rule out long-term adverse events.
    Tziakas DN; Chalikias GK; Stakos D; Chatzikyriakou SV; Papazoglou D; Mitrousi K; Lantzouraki A; Thomaidi A; Boudoulas H; Konstantinides S
    Eur J Prev Cardiol; 2012 Feb; 19(1):62-71. PubMed ID: 20479644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
    Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
    J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of osteopontin in patients with acute congestive heart failure.
    Behnes M; Brueckmann M; Lang S; Espeter F; Weiss C; Neumaier M; Ahmad-Nejad P; Borggrefe M; Hoffmann U
    Eur J Heart Fail; 2013 Dec; 15(12):1390-400. PubMed ID: 23851388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative value of B-type natriuretic peptide and serum albumin concentration in the prediction of in-hospital mortality in elderly patients admitted for acute severe heart failure].
    Arques S; Pieri B; Biegle G; Roux E; Gelisse R; Jauffret B
    Ann Cardiol Angeiol (Paris); 2009 Nov; 58(5):279-83. PubMed ID: 19819420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive cardiac troponin in the diagnosis and risk stratification of acute heart failure.
    Arenja N; Reichlin T; Drexler B; Oshima S; Denhaerynck K; Haaf P; Potocki M; Breidthardt T; Noveanu M; Stelzig C; Heinisch C; Twerenbold R; Reiter M; Socrates T; Mueller C
    J Intern Med; 2012 Jun; 271(6):598-607. PubMed ID: 21988283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure.
    Wong DT; George K; Wilson J; Manlhiot C; McCrindle BW; Adeli K; Kantor PF
    Am J Cardiol; 2011 Feb; 107(4):573-8. PubMed ID: 21295174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain natriuretic peptide for prediction of Cheyne-Stokes respiration in heart failure patients.
    Christ M; Sharkova Y; Fenske H; Rostig S; Herzum I; Becker HF; Mueller C; Grimm W
    Int J Cardiol; 2007 Mar; 116(1):62-9. PubMed ID: 16820230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome.
    Reardon LC; Williams RJ; Houser LS; Miner PD; Child JS; Aboulhosn JA
    Am J Cardiol; 2012 Nov; 110(10):1523-6. PubMed ID: 22863176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure.
    Sachdeva A; Horwich TB; Fonarow GC
    Am J Cardiol; 2010 Sep; 106(6):830-5. PubMed ID: 20816124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.